What does the evidence say about Magnesium Glycinate Sleep Latency Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Magnesium Glycinate Sleep Latency Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Therefore, a systematic review was performed to provide an updated examination of the clinical evidence on the use of magnesium for the treatment of the above conditions given the popularity of such supplements among patients and the public at large. [Rawji A (2024); evidence level 1] - Given the generally positive results across studies, the preponderance of preclinical evidence, and minimal side effects, however, supplemental magnesium is likely useful in the treatment of mild anxiety and insomnia, particularly in those with low magnesium status at baseline. [Rawji A (2024); evidence level 1] - Self-treatment with vitamin, mineral, and herbal supplements has become increasingly common among patients for the treatment of psychiatric disorders. [Rawji A (2024); evidence level 1] - Magnesium, in particular, is popular on social media for the treatment of anxiety and insomnia. [Rawji A (2024); evidence level 1] - Small sample size Short duration High Insomnia 11 Tunc et al 2023 938 279/659 81.1 / R ISI, ESS Elderly outpatient patients / / Hypomagnesemia is Associated with EDS Unknown if EDS leads to hypomagnesemia or vice versa. [He Caijun (2025); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.